106.28
-0.27
(-0.25%)
At close: 3:29:25 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
3,029,586
3,263,450
3,017,073
2,796,989
2,469,444
Cost of Revenue
1,711,209
1,951,860
1,762,439
1,678,183
1,527,169
Gross Profit
1,318,377
1,311,590
1,254,634
1,118,806
942,275
Operating Expense
1,089,789
1,086,088
1,079,184
968,209
771,397
Operating Income
228,588
225,502
175,450
150,597
170,878
Net Non Operating Interest Income Expense
-166,677
-148,814
-120,825
-105,387
-118,441
Pretax Income
82,955
90,473
47,485
91,823
41,026
Tax Provision
9,448
16,016
21,292
34,775
-6,096
Net Income Common Stockholders
72,555
73,922
25,717
56,115
47,423
Diluted NI Available to Com Stockholders
72,555
73,922
25,717
56,115
47,423
Basic EPS
4.87
4.94
1.67
3.79
3.34
Diluted EPS
4.87
4.94
1.67
3.79
3.34
Basic Average Shares
15,635.99
15,805
15,690
14,822
14,199
Diluted Average Shares
15,635.99
15,805
15,690
14,822
14,199
Rent Expense Supplemental
--
10,492
7,636
5,644
6,832
Total Expenses
2,800,998
3,037,948
2,841,623
2,646,392
2,298,566
Net Income from Continuing & Discontinued Operation
72,555
73,922
25,717
56,115
47,423
Normalized Income
71,822.19
73,146.60
24,703.77
40,155.24
47,803.10
Interest Income
--
5,596
2,313
3,701
3,142
Interest Expense
146,909
129,046
104,960
88,752
105,393
Net Interest Income
-166,677
-148,814
-120,825
-105,387
-118,441
EBIT
229,864
219,519
152,445
180,575
146,419
EBITDA
327,321
320,230
243,728
270,976
241,632
Reconciled Cost of Revenue
1,711,209
1,951,860
1,762,439
1,678,183
1,527,169
Reconciled Depreciation
97,457
100,711
91,283
90,401
95,213
Net Income from Continuing Operation Net Minority Interest
72,555
73,922
25,717
56,115
47,423
Total Unusual Items Excluding Goodwill
827
827
1,329
22,428
-543
Total Unusual Items
827
827
1,329
22,428
-543
Normalized EBITDA
326,494
319,403
242,399
248,548
242,175
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
94.19
51.60
315.77
6,468.24
-162.90
3/31/2021 - 1/2/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TYCHE.BO Tyche Industries Limited
147.15
+4.81%
SUNLOC.BO Sunil Healthcare Limited
73.88
+3.26%
PANCHSHEEL.BO Panchsheel Organics Limited
150.10
+1.42%
NATCAPSUQ.BO Natural Capsules Limited
234.80
+7.73%
CORALAB.BO Coral Laboratories Limited
667.15
+2.58%
BAJAJHCARE.BO Bajaj HealthCare Limited
622.95
+0.17%
NEULANDLAB.BO Neuland Laboratories Limited
12,742.10
+0.69%
LUPIN.BO Lupin Limited
1,935.80
-3.79%
GLAND.BO Gland Pharma Limited
1,443.25
+1.17%
LUPIN.NS Lupin Limited
1,934.20
-3.91%